Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibody Share News (FAB)

Share Price Information for Fusion Antibody (FAB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.40
Bid: 3.30
Ask: 3.50
Change: 0.00 (0.00%)
Spread: 0.20 (6.061%)
Open: 3.40
High: 3.40
Low: 3.40
Prev. Close: 3.40
FAB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Beeks Financial Cloud is ahead of expectations

Tue, 06th Feb 2024 10:05

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday.

----------

AIM - WINNERS

----------

Beeks Financial Cloud Group PLC, up 34% at 145.00 pence, 12-month range 81.42p-155.00p. The cloud computing and connectivity provider says it has won a number of competitive tenders in the first half of financial 2024, and now expects trading in financial 2025 to be "significantly" ahead of previous board expectations. Beeks notes that it has signed a USD2.3 million Proximity Cloud expansion contract, as well as a conditional contract with "one of the largest exchange groups globally." Chief Executive Gordon McArthur says: "We continue to progress with the execution of our 'land and expand' strategy, quickly demonstrating the value of our offerings, as evidenced by the significant Proximity Cloud expansion contract announced this morning and the winning of a third major global exchange customer for our Exchange Cloud offering. We see considerable expansion potential across our customers, as they migrate increasing proportions of their trading infrastructure to the cloud."

----------

Fusion Antibodies PLC, up 16% at 5.50p, 12-month range 3.02p-56.00p. Shares in the contract researcher rise. It receives a follow-on project under a collaborative research and development agreement with an unnamed "US-based biotechnology company". The follow on project is worth USD650,000. CEO Adrian Kinkaid says: "It is always thrilling and satisfying to share in our clients' successes. We are delighted that the programme has been so productive, and we look forward to continuing to work with our client to bring better antibodies to the clinic more rapidly. The collaborative nature of the project, with creative problem solving from both parties over the full length of the programme, makes this a model example of Fusion's Integrated Therapeutic Antibody Service and highlights the strong reputation that Fusion has for delivering high quality therapeutic antibodies."

----------

AIM - LOSERS

----------

PCI-PAL PLC, down 10% at 49.98p, 12-month range 38.25p-66.70p. Shares in the provider of cloud-based secure payment solutions for business communications fall despite a positive trading update. Revenue in the six months to December 31 rises 20% to GBP8.7 million from GBP7.3 million a year before. Annual recurring revenue in the period increases 23% to GBP14.7 million from GBP11.9 million. Looking ahead, CEO James Barham says: "The start of H2 has seen the group maintain new sales momentum and we continue to focus on delivering the group's profitability objectives, enhancing shareholder value, and capitalising on the strategic opportunities for continued growth."

----------

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
16 Feb 2021 14:24

IN BRIEF: Fusion Antibodies Hires Jones From BrYet To Replace CEO Kerr

IN BRIEF: Fusion Antibodies Hires Jones From BrYet To Replace CEO Kerr

Read more
11 Feb 2021 11:16

Omega Diagnostics Signs Contract To Make Covid Tests; Appoints Chair

Omega Diagnostics Signs Contract To Make Covid Tests; Appoints Chair

Read more
20 Nov 2020 13:25

Fusion Antibodies Half-Year Revenue Rises And Loss Narrows

Fusion Antibodies Half-Year Revenue Rises And Loss Narrows

Read more
13 Nov 2020 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
27 Oct 2020 15:15

IN BRIEF: Fusion Antibodies Gets Grant From Invest Northern Ireland

IN BRIEF: Fusion Antibodies Gets Grant From Invest Northern Ireland

Read more
24 Sep 2020 16:35

UK DIRECTOR DEALINGS SUMMARY: Supply@Me CEO Buys GBP1 Million Option

UK DIRECTOR DEALINGS SUMMARY: Supply@Me CEO Buys GBP1 Million Option

Read more
18 Sep 2020 21:16

IN BRIEF: Fusion Antibodies Surges On Virus Study Progress

IN BRIEF: Fusion Antibodies Surges On Virus Study Progress

Read more
18 Sep 2020 15:45

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
18 Sep 2020 09:48

Fusion Antibodies soars on Covid-19 test progress

(Sharecast News) - Fusion Antibodies shares soared after the antibody specialist said it had made progress on developing coronavirus antigen tests.

Read more
19 Aug 2020 09:15

Fusion Antibodies Posts Strong Annual Results As Ramps Up Services

Fusion Antibodies Posts Strong Annual Results As Ramps Up Services

Read more
11 Aug 2020 12:36

UK TRADING UPDATE SUMMARY: Codemasters On Up As Finds Right Formula

UK TRADING UPDATE SUMMARY: Codemasters On Up As Finds Right Formula

Read more
6 Jul 2020 16:02

IN BRIEF: Fusion Antibodies Expects Revenue Surge Amid Pandemic

IN BRIEF: Fusion Antibodies Expects Revenue Surge Amid Pandemic

Read more
6 Jul 2020 10:41

Fusion Antibodies FY revenues continue to grow in 2020

(Sharecast News) - Pre-clinical antibodies group Fusion Antibodies said on Monday that revenues had continued to grow over the year ending on 31 March.

Read more
28 Apr 2020 12:28

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

UK TRADING UPDATE SUMMARY: Zenith Latest To Join Global Drive For PPE

Read more
28 Apr 2020 11:19

Fusion Antibodies raises £3m for Covid-19 research

(Sharecast News) - Fusion Antibodies has raised £3m from investors to extend its research to cover potential treatments for Covid-19.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.